Pharmafile Logo
Pharmafocus logo
Advanced Search

Genzyme

Showing 15 posts of 98 posts found.

Genzyme confirms details of consent decree and $175m fine

May 27, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Lumizyme, Thyrogen, manufacturing compliance

Genzyme’s predictions on the penalties levied for the ongoing problems at its manufacturing facility in Allston Landing have been confirmed, …

News

FDA approves Genzyme’s Lumizyme

May 27, 2010
Sales and Marketing Genzyme, Lumizyme, Myozyme, Pompe disease

US biotech Genzyme is celebrating FDA approval of its late-onset treatment for Pompe disease Lumizyme. The green light to market …

News
Genzyme

Genzyme fined $175m for manufacturing problems

April 22, 2010
Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …

News

Genzyme appoint investor to outmanoeuvre Icahn

April 16, 2010
Sales and Marketing Contamination, Genzyme

Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …

News

FDA flexes muscles over ailing Genzyme plant

March 29, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Manufacturing compliance problems continue to weigh down US biotechnology company Genzyme, with the US Food and Drug Administration now saying …

News
Genzyme

Genzyme plays down Irish contamination

March 18, 2010
Manufacturing and Production Cerezyme, Contamination, Fabrazyme, Genzyme

The contamination problems plaguing Genzyme in the US have also appeared in product manufactured at its plant in Waterford, Ireland, …

News
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010
Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …

News

Pharma manufacturing news in brief

February 8, 2010
Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners

Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …

News

Manufacturing news in brief

January 25, 2010
Manufacturing and Production Elona Biotech, Genzyme, Lupin, Patheon, State Pharmaceuticals Manufacturing, SurModics

Our round-up of developments in pharmaceutical manufacturing includes a new contract between Patheon and Sanofi-Aventis, hiring plans at Genzyme and …

News

Ron Branning joins Genzyme

January 14, 2010
Manufacturing and Production Genzyme, appointment, manufacturing and production

Genzyme has appointed industry veteran Ron Branning as its new senior vice president of global product quality. Branning has 30 …

Appointment

Manufacturing news in brief

January 12, 2010
Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical

This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …

News

Hospira helps Genzyme tackle manufacturing problems

January 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Hospira

Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

News
Allston Landing

Genzyme hit by another contamination issue

November 30, 2009
Manufacturing and Production Cerezyme, Contamination, Genzyme

 Another manufacturing contamination issue has beset Genzyme, just as it seemed to be overcoming the problems at its Allston Landing …

News
Genzyme

Genzyme production in ‘recovery mode’

October 23, 2009
Manufacturing and Production Cerezyme, Genzyme

 

News

Genzyme says Cerezyme shortages could last longer than expected

August 17, 2009
Research and Development, Sales and Marketing Gaucher, Genzyme

The shortage of Genzyme's enzyme replacement therapy Cerezyme look set to last longer than expected, as the company has taken …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026